AstraZeneca CEO to President Moon: "South Korea is Our Top Priority Partner"

President Moon Meets AstraZeneca CEO in UK... "Discussed Cooperation on Next-Generation COVID-19 Vaccine"

[Asia Economy Reporter Ryu Jeong-min] Pascal Soriot, CEO of AstraZeneca, met with President Moon Jae-in in Cornwall, UK, on the 12th and said, "Considering that Korea is a top priority cooperation partner, we will make every effort," according to Park Kyung-mi, spokesperson for the Blue House.

When President Moon requested, "Please cooperate to ensure smooth supply of AstraZeneca vaccines in the second half of the year," CEO Soriot responded accordingly. He said, "SK Bioscience is a company showing the world's best performance in quality control of vaccine production, and we hope to maintain a long-term production cooperation relationship."

[Image source=Yonhap News]

President Moon said, "AstraZeneca is the first vaccine administered in Korea and the vaccine received by the most Koreans, making Korea a model country for AstraZeneca vaccination." He added, "I highly appreciate AstraZeneca's bold investment in innovative new drug research and development, which enabled the rapid development and distribution of the COVID-19 vaccine."

Spokesperson Park explained, "President Moon and CEO Soriot also exchanged views on cooperation between AstraZeneca and Korean pharmaceutical companies, the Korea Health Industry Development Institute, and domestic cancer centers regarding next-generation COVID-19 vaccines, heterologous vaccination, as well as cancer treatments and cardiovascular R&D."

President Moon stated, "I am confident that AstraZeneca will play a significant role in helping humanity overcome the pandemic and regain precious daily life," and conveyed, "Our government will actively cooperate in the production and supply of AstraZeneca vaccines." The meeting between President Moon and CEO Soriot lasted 22 minutes.

This content was produced with the assistance of AI translation services.